Cyclooxygenase-2 inhibitors: promise or peril?

Author： Mengle-Gaw Laurel J.   Schwartz Benjamin D.  

Publisher： Informa Healthcare

ISSN： 1466-1861

Source： Mediators of Inflammation, Vol.11, Iss.5, 2002-10, pp. : 275-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

By Fosslien Egil  

Critical Reviews in Clinical Laboratory Sciences, Vol. 37, Iss. 5, 2000-09 ,pp. : 431-502

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular effects of cyclooxygenase‐2 inhibitors: a mechanistic and clinical perspective

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 82, Iss. 4, 2016-10 ,pp. : 957-964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Topically Applied Cyclooxygenase-2-Selective Inhibitors on Arachidonic Acid- and Tetradecanoylphorbol Acetate-Induced Dermal Inflammation in the Mouse

By Puigneró Violant   Queralt Josep  

Inflammation, Vol. 21, Iss. 4, 1997-08 ,pp. : 431-442

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs

By Hermann Matthias   Ruschitzka Frank  

Annals of Medicine, Vol. 39, Iss. 1, 2007-01 ,pp. : 18-27

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase-2 Expression in Chondrosarcoma

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 275-280

Karger

Access to resources Recommend Favorite